Baseline intestinal absorption and synthesis of cholesterol regulate its response to hypolipidaemic treatments in coronary patients


      Baseline cholesterol metabolism was hypothesized to regulate responses of cholesterol synthesis and absorption, and serum cholesterol lowering to hypolipidaemic treatment. Thus, serum cholesterol and non-cholesterol sterols were measured before and during long-term simvastatin treatment (inhibition of cholesterol synthesis) and subsequent combination of statin with plant stanol ester margarine (inhibition of cholesterol absorption) consumption in subjects with low (n=15) and high (n=15) absorption of cholesterol, defined by respective low and high baseline ratios of serum cholestanol to cholesterol. Cholesterol synthesis (defined by precursors of cholesterol) was markedly reduced by the long-term statin treatment in both groups, but more extensively in the low than high absorption group (P<0.05), yet the respective serum cholesterol reductions were similar. From among the absorption markers, sitosterol and cholestanol ratios were correspondingly increased more in the low than in the high absorption group. Plant stanol ester margarine consumption, combined with chronic statin treatment, further lowered the serum cholesterol level (P<0.001) only in the high absorption group. The sum of cholesterol absorption markers was reduced more (P<0.05) in the high than in the low absorption group, while the non-significant serum cholesterol reduction of the low absorption group was associated with relatively high increase of cholesterol synthesis. Thus, stanol ester margarine combined with chronic simvastatin treatment reduces cholesterol absorption and serum cholesterol more consistently in subjects with high than low baseline absorption of cholesterol. The profile of baseline cholesterol metabolism determines the changes in synthesis and absorption of cholesterol to hypolipidaemic treatments, but affects less differently serum cholesterol level.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Scandinavian Simvastatin Survival Group
        Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S).
        Lancet. 1994; 344: 1383-1389
        • Scandinavian Simvastatin Survival Study Group
        Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S).
        Lancet. 1995; 345: 1274-1275
        • Miettinen T.A.
        • Tilvis R.S.
        • Kesäniemi Y.A.
        Serum cholestanol and plant sterol levels in relation to cholesterol metabolism in middle-aged men.
        Metabolism. 1989; 38: 136-140
        • Miettinen T.A.
        • Tilvis R.S.
        • Kesäniemi Y.A.
        Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population.
        Am. J. Epidemiol. 1990; 131: 20-31
        • Miettinen T.A.
        • Gylling H.
        • Strandberg T.
        • Sarna S.
        • for the Finnish 4S Investigators
        Baseline serum cholestanol predicts recurrent coronary events in a subgroup of the Scandinavian Simvastatin Survival Study (4S).
        Br. Med. J. 1998; 316: 1127-1130
        • Miettinen T.A.
        • Strandberg T.E.
        • Gylling H.
        • for the Finnish Investigators of the Scandinavian Simvastatin Survival Study Group
        Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients. Relation to basal serum cholestanol.
        Arterioscler. Thromb. Vasc. Biol. 2000; 20: 1340-1346
        • Miettinen T.A.
        • Puska P.
        • Gylling H.
        • Vanhanen H.
        • Vartiainen E.
        Serum cholesterol lowering by sitostanol ester margarine in a mildly hypercholesterolemic random population.
        N. Engl. J. Med. 1995; 333: 1308-1312
        • Gylling H.
        • Puska P.
        • Vartiainen E.
        • Miettinen T.A.
        Serum sterols during stanol ester feeding in a mildly hypercholesterolemic population.
        J. Lipid. Res. 1999; 40: 593-600
        • Miettinen T.A.
        Gas-liquid chromatographic determination of fecal neutral sterols using a capillary column.
        Clin. Chim. Acta. 1982; 124: 245-248
        • Miettinen T.A.
        Cholesterol metabolism during ketoconazole treatment in man.
        J. Lipid. Res. 1988; 29: 43-51
      1. Dixon WJ. BMDP Statistical Software Manual,.vols. 1–2. Berkeley University of California Press Berkeley, Los Angeles, CA, 1992.

        • Berge K.E.
        • Tian H.
        • Graf G.A.
        • Yu L.
        • Grishin N.V.
        • Schultz J.
        • Kwiterovich P.
        • Shan B.
        • Barnes R.
        • Hobbs H.H.
        Accumulation of dietary cholesterol in sitosterolemia caused by mutations in adjacent ABC transporters.
        Science. 2000; 290: 1771-1775
        • Lee M.-H.
        • Lu K.
        • Patel S.B.
        Genetic basis of sitosterolemia.
        Curr. Opin. Lipidol. 2001; 12: 141-149
        • Miettinen T.A.
        Detection of changes in human cholesterol metabolism.
        Ann. Clin. Res. 1970; 2: 300-320
        • Miettinen T.A.
        Serum methyl sterols and their distribution between major lipoprotein fractions in different clinical conditions.
        Ann. Clin. Res. 1971; 3: 264-271
        • Björkhem I.
        • Miettinen T.A.
        • Reihner E.
        • Ewerth S.
        • Angelin B.
        • Einarsson K.
        Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver.
        J. Lipid. Res. 1987; 28: 1137-1143
        • Björkhem I.
        • Boberg K.M.
        Inborn errors in bile acid biosynthesis and storage of sterols other than cholesterol.
        in: Scriver C.R. Beaudet A.L. Sly W.S. Valle D. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. McGraw-Hill, New York1995: 2073-2099
        • Glueck C.J.
        • Speirs J.
        • Tracy T.
        • Streicher P.
        • Illig E.
        • Vandegrift J.
        Relationships of serum plant sterols (phytosterols) and cholesterol in 595 hypercholesterolemic subjects, and familial aggregation of phytosterols, cholesterol, and premature coronary heart disease in hyperphytosterolemic probands and their first-degree relatives.
        Metabolism. 1991; 40: 842-848
        • Gylling H.
        • Rajaratnam R.
        • Miettinen T.A.
        Reduction of serum cholesterol in postmenopausal coronary women with cholesterol malabsorption induced by dietary sitostanol ester margarine.
        Circulation. 1997; 96: 4226-4231